274 related articles for article (PubMed ID: 19242993)
1. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
[TBL] [Abstract][Full Text] [Related]
2. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
3. Interlaboratory variability in assessment of the model of end-stage liver disease score.
Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based incorporation of serum sodium concentration into MELD.
Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
[TBL] [Abstract][Full Text] [Related]
5. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
8. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
9. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
10. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
[TBL] [Abstract][Full Text] [Related]
11. Application of a continuous disease severity score to the OPTN liver waiting list.
Edwards EB; Harper AM
Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
[TBL] [Abstract][Full Text] [Related]
12. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
13. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
14. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
[TBL] [Abstract][Full Text] [Related]
15. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.
Trotter JF; Brimhall B; Arjal R; Phillips C
Liver Transpl; 2004 Aug; 10(8):995-1000. PubMed ID: 15390325
[TBL] [Abstract][Full Text] [Related]
16. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
[TBL] [Abstract][Full Text] [Related]
17. [The value of MELD in the allocation of priority for liver transplantation candidates].
Colmenero J; Castro-Narro G; Navasa M
Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
[TBL] [Abstract][Full Text] [Related]
18. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.
Yoo HY; Edwin D; Thuluvath PJ
Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
Hsu CY; Lin HC; Huang YH; Su CW; Lee FY; Huo TI; Lee PC; Lee JY; Lee SD
Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
[TBL] [Abstract][Full Text] [Related]
20. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
